VC-backed Roche Holdings buys Inception 5 program
Roche Holdings, which is backed by Versant Ventures, has acquired the Inception 5 program. No financial terms were disclosed. Inception is focused on regenerative therapies for multiple sclerosis.
4 April 2018•3 mins read
